Background
Due to waning levels of maternal antibodies (measles; enterovirus 71, EV71; and coxsackievirus A16, CoxA16), some infants may lose protection against infection prior to vaccination. Using a longitudinal design, we examine how maternal antibody levels evolve over time in infants prior to vaccination.
Methods
In 2013–2014, we collected sera at ages 0, 3 and 6 months from infants. We assayed for levels of measles IgG antibody (717, 233 and 75 sample sera tested at months 0, 3 and 6, respectively), and neutralizing antibodies for EV71 and CoxA16 (225, 217, and 72). Demographic and health information were collected, and a linear mixed model (LMM) was used to describe antibody levels over time.
Results
Pre-vaccination monotonic antibody decreases were observed for measles (1410, 195 and 22 mIU/ml, p < 0.001), EV71 (1:19.9, 6.3 and 4.5, p < 0.001) and CoxA16 (1:16.3, 5.9, and 4.5, p < 0.001). At 6 months of age, only 2.7% (95%CI, 0.6–8.3), 6.8% (95%CI, 2.7–14.4) and 5.6% (95%CI, 1.9–12.7) of infants were antibody positive for measles, EV71 and CoxA16, respectively. LMM findings indicated that infants with higher antibody titers at birth experienced a greater loss of antibody level. An infection rate of 1.3% (95%CI, 0.1–6.1) was reported for both EV71 and CoxA16.
Conclusions
Further modifications of vaccination strategies for measles, earlier vaccination for EV71 infection, and deployment of a CoxA16 vaccine need to be considered to limit infection among the very young.